Skip to main content

A Randomized, Open-Label, Phase 2 Study Evaluating Abemaciclib in Combination With Temozolomide Compared to Temozolomide Monotherapy in Children and Young Adults With Newly Diagnosed High-Grade Glioma Following Radiotherapy

Open
  • Protocol code: I3Y-MC-JPEH
  • EudraCT code: No aplica
  • Research group: Childhood Cancer and Blood Disorders
  • Service: Pediatric Oncohematology
  • Principal investigator:  Llort Sales, Anna
  • Pathology: Tumors
  • Phase: Fase II
  • Status: Recruiting volunteers